secwatch.observer — SEC 8-K summary
======================================

Issuer:     CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)
CIK:        0001801170
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001801170-22-000038
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clover Health appoints Dr. Carladenise Edwards to Board of Directors
--------------------------------------------------------------------

- Dr. Edwards appointed Class III director effective July 22, 2022.
- She will serve on Talent and Compensation and Nominating and Corporate Governance Committees.
- Receives pro rata director retainer for 2022 and $200K RSU award prorated through Sept 22, 2022 annual meeting.
- Edwards is EVP & Chief Strategy Officer at Henry Ford Health System with 30 years healthcare experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000038/0001801170-22-000038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1801170/000180117022000038/clov-20220722.htm
  HTML page:      https://secwatch.observer/filing/0001801170-22-000038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer